Monday, 26 March 2018
EMPENTA is the acceleration and support program for technology-based companies promoted by ACCIÓ (Catalan Government) and led by ESADE and ESADECREAPOLIS. In its seventh edition over 130 projects have been registered, doubling the numbers of the previous edition.
Tuesday, 23 January 2018
Ahead Therapeutics SL is the result of a joint research project with a strong nano component between the Germans Trias i Pujol Research Institute (IGTP), the ICN2 and ICREA. It was created to advance the development of therapies for autoimmune diseases and pursue their application in a clinical setting. Just a few months in, the new company has already attracted 1.1 million euros in private investment.
Tuesday, 12 December 2017
In 2012 the ICN2, ICREA and Chemipol signed a licence agreement for the joint development of innovative antifungal paint based on micro- and nanoencapsulation technologies. This technology has been on the market since 2015, and is the third commercial product to emerge from the ICN2.
Tuesday, 19 December 2017
This initiative, managed by the ICN2 and scientifically coordinated by the ICN2 and ICFO, will promote a strong community to develop cutting-edge graphene technologies for and by Catalan industry. It was presented on 4 December this year at the ICN2, in an event to kick start the creation of a project portfolio that simultaneously drives progress and showcases regional excellence.
Tuesday, 12 December 2017
The project Nanoplastics, launched by researchers at the Catalan Institute for Nanoscience and Nanotechnology (ICN2), the Institute for Neurosciences (INC-UAB) and the Centre for Agronomic Research (CRAG), has created a single-layer biodegradable film to increase safety of packaged and extend their shelf life.
